Pharmacoeconomic analysis of the use of gazyva (obinutuzumab) for the treatment of chronic lymphocytic leukemia in the Russian Federation

Autor:	V.V. Babiy, A.Yu. Kulikov
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty chemistry.chemical_compound chemistry business.industry Obinutuzumab Internal medicine Chronic lymphocytic leukemia medicine Russian federation medicine.disease business
Zdroj:	Pharmacoeconomics: theory and practice. 3:61-65
ISSN:	2312-2862
DOI:	10.30809/phe.2.2015.5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2e29875a0339fe2df418979bef67839b https://doi.org/10.30809/phe.2.2015.5 Zobrazit plný text záznamu